The innovative drug concept fluctuated and rebounded. Dezhan Health's 3-day 2 board, Hao Oubo rose nearly 10%, and Qianjin Pharmaceutical, Wanbang Pharmaceutical, Borui Pharmaceutical, and Harbin Pharmaceutical Co., Ltd. followed suit.

Zhitongcaijing · 2d ago
The innovative drug concept fluctuated and rebounded. Dezhan Health's 3-day 2 board, Hao Oubo rose nearly 10%, and Qianjin Pharmaceutical, Wanbang Pharmaceutical, Borui Pharmaceutical, and Harbin Pharmaceutical Co., Ltd. followed suit.